Edizon Innovation and Strategyn have worked with hundreds of companies and have taught thousands of people the power of JTBD and ODI.
Special Topic: “Learn how to strategically align the efforts of product management, R&D, marketing and sales with customer needs”.
Get to know the principles of Jobs-to-be-Done thinking according to the five steps of the Outcome-Driven Innovation® process in this 3×0,5-day online live strategy workshop. The workshop will go through all ODI steps in detail and will be with Marco De Polo from Roche Diabetes Care who has already executed ODI Projects with Edizon.
This workshop will give you new insights for your strategic product planning and product development. Furthermore, it will support you to plan the future. It will help you to understand your existing (and new) customers and to develop product or service offerings they really want.
What you will learn:
What you will get:
Online live (CET)
EUR 1,040 online price (normal price EUR 1,490)
Prices excl. 20% VAT.
Special offer 2+1: Participate in a group of 3, pay for 2! (please add this in the field for Remarks)
“Edizon’s Outcome-Driven Innovation approach finally allowed us to truly understand what customers are trying to achieve, independent of any solutions. Edizon opened our eyes regarding the ultimate unit of measure to identify growth opportunities and growth strategies: the jobs and outcomes customers are trying to get done that then define the opportunity landscape.”
Marco will give more insights in our JTBD MASTER CLASS ADVANCED on October 20-22, 2020.
“Identify an urgent and important business challenge or business objective – then prove that an ODI like investment can do the job better, faster, more effective – focus on a “quick win” with clear metrics – most importantly: build allies and establish a compelling, “emotional” story with a mission that people want to be part of it.”
“We reduce wasted $ because we have clear priorities for who to create value for (customer value and business value).”
Marco De Polo is Global Head Strategic Insights & Open Innovation at Roche Diagnostics.